142 related articles for article (PubMed ID: 12544735)
1. Acquired factor V inhibitor complicated by Hashimoto's thyroditis, primary biliary cirrhosis and membranous nephropathy.
Takahashi H; Fuse I; Abe T; Yoshino N; Aizawa Y
Blood Coagul Fibrinolysis; 2003 Jan; 14(1):87-93. PubMed ID: 12544735
[TBL] [Abstract][Full Text] [Related]
2. Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding.
Ajzner E; Balogh I; Haramura G; Boda Z; Kalmár K; Pfliegler G; Dahlbäck B; Muszbek L
J Thromb Haemost; 2003 May; 1(5):943-9. PubMed ID: 12871359
[TBL] [Abstract][Full Text] [Related]
3. Clinical and laboratory diagnosis of autoimmune factor V inhibitors: A single institutional experience.
Sridharan M; Fylling KA; Ashrani AA; Chen D; Marshall AL; Hook CC; Cardel LK; Nichols WL; Pruthi RK
Thromb Res; 2018 Nov; 171():14-21. PubMed ID: 30227314
[TBL] [Abstract][Full Text] [Related]
4. [Acquired factor V inhibitors in a polytraumatized patient].
Tukić L; Stamatović D; Tarabar O; Elez M; Zorić M; Mandić-Radić S
Vojnosanit Pregl; 2005; 62(7-8):587-90. PubMed ID: 16171024
[TBL] [Abstract][Full Text] [Related]
5. A case of primary biliary cirrhosis associated with Hashimoto's thyroiditis, scleroderma and Sjögren's syndrome.
Horita M; Takahashi N; Seike M; Nasu S; Takaki R
Intern Med; 1992 Mar; 31(3):418-21. PubMed ID: 1611199
[TBL] [Abstract][Full Text] [Related]
6. Multimodality therapy of an acquired factor V inhibitor.
Fu YX; Kaufman R; Rudolph AE; Collum SE; Blinder MA
Am J Hematol; 1996 Apr; 51(4):315-8. PubMed ID: 8602633
[TBL] [Abstract][Full Text] [Related]
7. Sibling cases of primary biliary cirrhosis associated with polymyositis, vasculitis and Hashimoto's thyroiditis.
Harada N; Dohmen K; Itoh H; Ohshima T; Yamamoto H; Nagano M; Iwata Y; Hachisuka K; Ishibashi H
Intern Med; 1992 Feb; 31(2):289-93. PubMed ID: 1600281
[TBL] [Abstract][Full Text] [Related]
8. [Three patients with nephrotic syndrome due to membranous nephropathy complicated by Sjögren's syndrome].
Baba A; Hara S; Sato Y; Yamada K; Fujimoto S; Eto T
Nihon Jinzo Gakkai Shi; 2005; 47(8):882-6. PubMed ID: 16408433
[TBL] [Abstract][Full Text] [Related]
9. Membranous nephropathy with acquired factor V inhibitor: a case report.
Kitamura S; Misawa M; Namba S; Tsuji K; Torigoe R; Shima M; Makino H
BMC Res Notes; 2013 Dec; 6():553. PubMed ID: 24360027
[TBL] [Abstract][Full Text] [Related]
10. [Case of membranous glomerulonephritis associated with biliary cirrhosis and chronic thyroiditis].
Tanaka T; Maezawa A; Matsuda H; Hiromura K; Yano S; Narikiyo T; Yamada S
Nihon Naika Gakkai Zasshi; 1994 Jun; 83(6):995-6. PubMed ID: 7964057
[No Abstract] [Full Text] [Related]
11. Modulation of an acquired coagulation factor V inhibitor with intravenous immune globulin.
Tarantino MD; Ross MP; Daniels TM; Nichols WL
J Pediatr Hematol Oncol; 1997; 19(3):226-31. PubMed ID: 9201145
[TBL] [Abstract][Full Text] [Related]
12. PBC-AIH overlap syndrome with concomitant ITP and Hashimoto's disease with positivity for anti-centromere antibody.
Arakawa Y; Amaki S; Miyakawa H; Sakai T; Gotou I; Tanaka N; Moriyama M; Iwasaki A; Sugitani M; Arakawa Y
J Gastroenterol; 2004; 39(5):490-5. PubMed ID: 15175950
[TBL] [Abstract][Full Text] [Related]
13. Study on an antibody against F1F2 fragment of human factor V in a patient with Hashimoto's disease and bullous pemphigoid.
Suehisa E; Toku M; Akita N; Fushimi R; Takano T; Tada H; Iwatani Y; Amino N
Thromb Res; 1995 Jan; 77(1):63-8. PubMed ID: 7701478
[TBL] [Abstract][Full Text] [Related]
14. Transfusion management of factor V deficiency: three case reports and review of the literature.
Gavva C; Yates SG; Rambally S; Sarode R
Transfusion; 2016 Jul; 56(7):1745-9. PubMed ID: 27125565
[TBL] [Abstract][Full Text] [Related]
15. High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors.
de Raucourt E; Barbier C; Sinda P; Dib M; Peltier JY; Ternisien C
Am J Hematol; 2003 Nov; 74(3):187-90. PubMed ID: 14587047
[TBL] [Abstract][Full Text] [Related]
16. Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency.
Ashizawa M; Kimura S; Wada H; Sakamoto K; Sato M; Terasako K; Kikuchi M; Nakasone H; Okuda S; Kako S; Yamazaki R; Oshima K; Matsuura K; Ohmori T; Madoiwa S; Nishida J; Mimuro J; Tabei K; Sakata Y; Kanda Y
Hematology; 2013 Sep; 18(5):300-4. PubMed ID: 23683688
[TBL] [Abstract][Full Text] [Related]
17. A high titer of acquired factor V inhibitor in a hemodialysis patient who developed arterial thrombosis.
Ogawa H; Souri M; Kanouchi K; Osaki T; Ohkubo R; Kawanishi T; Wakai S; Morikane K; Ichinose A
Int J Hematol; 2019 Feb; 109(2):214-220. PubMed ID: 30446942
[TBL] [Abstract][Full Text] [Related]
18. [Acquired factor V deficiency: a rare bleeding disorder with variable clinical presentations].
Alcantara M; Ducastelle S; Rugeri L; Dargaud Y
Rev Med Interne; 2011 May; 32(5):e59-61. PubMed ID: 20638758
[TBL] [Abstract][Full Text] [Related]
19. Hashimoto's thyroiditis, primary biliary cirrhosis, and myasthenia gravis.
Rajaraman S; Deodhar SD; Carey WD; Salanga VD
Am J Clin Pathol; 1980 Dec; 74(6):831-4. PubMed ID: 6893788
[TBL] [Abstract][Full Text] [Related]
20. Acquired factor V inhibitor with erythema and eosinophilia in a patient with end-stage renal disease.
Katsuren E; Kohagura K; Kinjyo T; Zamami R; Nakamura T; Oshiro N; Sunagawa Y; Omine K; Kudo Y; Shinzato Y; Osaki T; Souri M; Ichinose A; Yamazato M; Ishida A; Ohya Y
CEN Case Rep; 2023 Feb; 12(1):91-97. PubMed ID: 35943699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
